162 related articles for article (PubMed ID: 21362456)
1. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
[TBL] [Abstract][Full Text] [Related]
2. Orexins promote survival of rat cortical neurons.
Sokołowska P; Urbańska A; Namiecińska M; Biegańska K; Zawilska JB
Neurosci Lett; 2012 Jan; 506(2):303-6. PubMed ID: 22138089
[TBL] [Abstract][Full Text] [Related]
3. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.
Putula J; Turunen PM; Johansson L; Näsman J; Ra R; Korhonen L; Kukkonen JP
FEBS Lett; 2011 May; 585(9):1368-74. PubMed ID: 21510948
[TBL] [Abstract][Full Text] [Related]
4. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
[TBL] [Abstract][Full Text] [Related]
5. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation.
Okumura T; Takeuchi S; Motomura W; Yamada H; Egashira Si S; Asahi S; Kanatani A; Ihara M; Kohgo Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):976-81. PubMed ID: 11162621
[TBL] [Abstract][Full Text] [Related]
6. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B.
Asahi S; Egashira S; Matsuda M; Iwaasa H; Kanatani A; Ohkubo M; Ihara M; Morishima H
Bioorg Med Chem Lett; 2003 Jan; 13(1):111-3. PubMed ID: 12467628
[TBL] [Abstract][Full Text] [Related]
7. Multiple phospholipase activation by OX(1) orexin/hypocretin receptors.
Johansson L; Ekholm ME; Kukkonen JP
Cell Mol Life Sci; 2008 Jun; 65(12):1948-56. PubMed ID: 18488139
[TBL] [Abstract][Full Text] [Related]
8. The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands.
Xu TR; Ward RJ; Pediani JD; Milligan G
Biochem J; 2011 Oct; 439(1):171-83. PubMed ID: 21770891
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.
Langmead CJ; Jerman JC; Brough SJ; Scott C; Porter RA; Herdon HJ
Br J Pharmacol; 2004 Jan; 141(2):340-6. PubMed ID: 14691055
[TBL] [Abstract][Full Text] [Related]
10. SB-334867-A: the first selective orexin-1 receptor antagonist.
Smart D; Sabido-David C; Brough SJ; Jewitt F; Johns A; Porter RA; Jerman JC
Br J Pharmacol; 2001 Mar; 132(6):1179-82. PubMed ID: 11250867
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras.
Putula J; Kukkonen JP
Neurosci Lett; 2012 Jan; 506(1):111-5. PubMed ID: 22079339
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
[TBL] [Abstract][Full Text] [Related]
13. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
Voisin T; Firar AE; Avondo V; Laburthe M
Endocrinology; 2006 Oct; 147(10):4977-84. PubMed ID: 16857748
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
15. Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.
Johansson L; Ekholm ME; Kukkonen JP
Br J Pharmacol; 2007 Jan; 150(1):97-104. PubMed ID: 17115071
[TBL] [Abstract][Full Text] [Related]
16. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
[TBL] [Abstract][Full Text] [Related]
17. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
18. OX1 orexin/hypocretin receptor signaling through arachidonic acid and endocannabinoid release.
Turunen PM; Jäntti MH; Kukkonen JP
Mol Pharmacol; 2012 Aug; 82(2):156-67. PubMed ID: 22550093
[TBL] [Abstract][Full Text] [Related]
19. The NMR-derived conformation of orexin-A: an orphan G-protein coupled receptor agonist involved in appetite regulation and sleep.
Miskolzie M; Kotovych G
J Biomol Struct Dyn; 2003 Oct; 21(2):201-10. PubMed ID: 12956605
[TBL] [Abstract][Full Text] [Related]
20. Involvement of TRPC3 channels in calcium oscillations mediated by OX(1) orexin receptors.
Peltonen HM; Magga JM; Bart G; Turunen PM; Antikainen MS; Kukkonen JP; Akerman KE
Biochem Biophys Res Commun; 2009 Jul; 385(3):408-12. PubMed ID: 19464259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
